Bio-Techne Corp (TECH)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $11.43B
Last updated: Nov 17, 2026 at 4:34 PM ET
Bio-Techne Corp (TECH) Statistics
Bio-Techne (TECH) has a market cap of $11.43B and an enterprise value of $11.28B. Its trailing P/E is 39.5x.
Total Valuation
Enterprise value is 1.31% below the market cap, as cash exceeds debt.
| Market Cap | $11.43B |
|---|---|
| Enterprise Value | $11.28B |
| Latest price (Nov 17, 2026) | $72.63 |
Key Dates
The next earnings report is expected on Feb 2, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 13, 2026.
| Next Earnings Date | Feb 2, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 3, 2026 |
| Last Ex-Dividend Date | Nov 13, 2026 |
| Next Payment Date | Nov 23, 2026 |
| Fiscal Year End | June |
Valuation Ratios
Sales and book value multiples are 9.3x and 5.3x. Its year-end P/E ranged from 28.9x to 69.9x from 2016 to 2025.
| P/E Ratio | 39.5x |
|---|---|
| Forward P/E | 35.0x |
| P/S Ratio | 9.3x |
| Forward P/S | 8.9x |
| P/B Ratio | 5.3x |
| P/TBV Ratio | 12.6x |
| P/FCF Ratio | 37.0x |
| P/OCF Ratio | 33.9x |
| PEG Ratio | 4.6 |
Enterprise Valuation
Counting debt and cash, the company is valued at 33.3x EBITDA and 36.5x free cash flow.
| EV / Earnings | 65.6x |
|---|---|
| EV / Sales | 9.2x |
| EV / EBITDA | 33.3x |
| EV / EBIT | 46.9x |
| EV / FCF | 36.5x |
Price Statistics
The stock is up 22.64% over 52 weeks and trades 0.22% above its 50-day average.
| Beta (1Y) | 0.61 |
|---|---|
| 52-Week Change | +22.64% |
| 1-Month Change | +0.30% |
| 3-Month Change | +0.43% |
| 6-Month Change | +59.91% |
| 5-Year Change | -44.50% |
| 10-Year Change | +179.49% |
| Total Return (1Y) | +23.18% |
| Total Return (3Y CAGR) | +6.31% |
| Total Return (5Y CAGR) | -9.80% |
| Return vs SPY (1Y) | +13.51% |
| Max Drawdown (1Y) | -39.32% |
| Max Drawdown (3Y) | -48.30% |
| Sharpe Ratio (1Y) | 0.53 |
| Correlation with SPY (1Y) | 0.20 |
| 50-Day Average | $72.47 |
| 200-Day Average | $63.35 |
| 52-Week Range | $42.98 to $72.85 |
| RSI (14 Days) | 52.2 |
| Average Volume (20 Days) | 3.17M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.28x current liabilities, and total debt is 0.09x shareholder equity.
| Current Ratio | 2.28x |
|---|---|
| Quick Ratio | 1.74x |
| Debt / Equity | 0.09x |
| Debt / EBITDA | 0.59x |
| Debt / FCF | 0.65x |
| Interest Coverage | 25.55x |
Returns and Efficiency
Return on invested capital is 7.70% over the last 12 months, against a 5-year average of 9.09%.
| Return on Equity (ROE) | 7.94% |
|---|---|
| Return on Assets (ROA) | 6.52% |
| Return on Invested Capital (ROIC) | 7.70% |
| Return on Capital Employed (ROCE) | 10.58% |
| ROE (5Y Average) | 10.11% |
| ROA (5Y Average) | 7.68% |
| ROIC (5Y Average) | 9.09% |
| Asset Turnover | 0.48x |
| Inventory Turnover | 2.14x |
| Receivables Turnover | 5.85x |
| Cash Conversion Cycle | 208 days |
Taxes
Income tax took 24.37% of pretax income over the last 12 months.
| Income Tax (TTM) | $55.41M |
|---|---|
| Effective Tax Rate | 24.37% |
Scores
TECH has an Altman Z-Score of 16.09, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 16.09 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 8 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue of $1.23B over the last 12 months is up 0.94% from the 12 months before.
| Revenue | $1.23B |
|---|---|
| Revenue Growth (YoY) | +0.94% |
| Gross Profit | $807.58M |
| Operating Income | $240.84M |
| Pretax Income | $227.38M |
| Net Income | $171.97M |
| EBITDA | $337.58M |
| EBIT | $240.84M |
| Reported EPS (TTM) | $1.84 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 82.20% of the $2.64B in total assets.
| Cash and Equivalents | $350.04M |
|---|---|
| Total Debt | $200.00M |
| Net Cash | $150.04M |
| Net Cash Per Share | $0.96 |
| Working Capital | $463.56M |
| Shareholder Equity | $2.17B |
| Book Value Per Share | $13.81 |
| Tangible Book Value | $906.58M |
| Tangible Book Per Share | $5.78 |
| Total Assets | $2.64B |
| Total Liabilities | $471.13M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $29.40M of capital spending, operating cash flow left $308.20M of free cash flow.
| Operating Cash Flow | $337.60M |
|---|---|
| Capital Expenditures | $29.40M |
| Free Cash Flow | $308.20M |
| FCF Per Share | $1.96 |
| Depreciation and Amortization | $96.75M |
| Dividends Paid | $50.03M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 19.61%, against a 5-year average of 20.01%.
| Gross Margin | 65.75% |
|---|---|
| Operating Margin | 19.61% |
| Pretax Margin | 18.51% |
| Net Margin | 14.00% |
| EBITDA Margin | 27.49% |
| EBIT Margin | 19.61% |
| FCF Margin | 25.09% |
| Gross Margin (5Y Average) | 66.62% |
| Operating Margin (5Y Average) | 20.01% |
| Net Margin (5Y Average) | 16.88% |
Growth
Revenue grew 2.25% a year over 3 years, and EPS fell 2.74% a year.
| Revenue Growth (3Y CAGR) | +2.25% |
|---|---|
| Revenue Growth (5Y CAGR) | +5.47% |
| EPS Growth (3Y CAGR) | -2.74% |
| EPS Growth (5Y CAGR) | +1.72% |
| FCF Growth (3Y CAGR) | +6.79% |
| FCF Growth (5Y CAGR) | -3.08% |
| Operating Income Growth (3Y CAGR) | -5.55% |
Dividends and Yields
TECH pays out 14.86% of earnings as dividends.
| Dividend Per Share (Annual) | $0.32 |
|---|---|
| Dividend Yield | 0.44% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | 0.00% |
| Dividend Growth (5Y CAGR) | 0.00% |
| Payout Ratio | 14.86% |
| FCF Payout Ratio | 16.23% |
| Earnings Yield | 2.53% |
| FCF Yield | 2.71% |
| Buyback Yield | 0.37% |
| Shareholder Yield | 0.80% |
Stock Splits
The last split was a 4-for-1 forward split on Nov 30, 2022.
| Last Split Date | Nov 30, 2022 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 4:1 |
Peer Position
Against 5 similar companies, TECH has the 4th highest P/E and the 3rd highest ROIC.
P/E RatioPeer median 40.4x
P/S RatioPeer median 15.1x
ROICPeer median -33.00%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +37.28%
| P/E Ratio | 39.5x vs 40.4x median |
|---|---|
| P/S Ratio | 9.3x vs 15.1x median |
| ROIC | 7.70% vs -33.00% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +0.94% vs +37.28% median |
Analyst Forecast
Consensus estimates put revenue growth at 7.21% and EPS growth at 12.10% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +7.21% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +12.10% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About TECH
What is TECH's market cap?
Bio-Techne has a market cap of $11.43B. Its enterprise value, which adds debt and subtracts cash, is $11.28B.
What is TECH's P/E ratio?
Bio-Techne has a trailing P/E ratio of 39.5x and a forward P/E of 35.0x.
How many shares of TECH are outstanding?
Bio-Techne has 156.80M shares outstanding. The count is up 0.86% from a year earlier.
Does TECH pay a dividend?
Yes. Bio-Techne pays $0.32 a share a year, a dividend yield of 0.44%.
How much debt does TECH have?
Bio-Techne has $200.00M of total debt and $350.04M of cash and equivalents, a net cash position of $150.04M.
TECH pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors